郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.

期刊：PLoS biology发表年份：2019作者：Teresa Buenaventura; Stavroula Bitsi; William E Laughlin; Thomas Burgoyne; Zekun Lyu; Affiong I Oqua; Hannah Norman; Emma R McGlone; Andrey S Klymchenko; Ivan R Corrêa; Abigail Walker; Asuka Inoue; Aylin Hanyaloglu; Jak Grimes; Zsombor Koszegi; David
阅读更多 →

代谢疾病Comparison of metabolic and mitogenic response in vitro of the rapid-acting insulin lispro product SAR342434, and US- and EU-approved Humalog®.

期刊：Regulatory toxicology and pharmacology : RTP发表年份：2019作者：Marcus Korn; Paulus Wohlfart; Thomas Gossas; Mari Kullman-Magnusson; Birgit Niederhaus; Juergen Dedio; Norbert Tennagels
阅读更多 →

代谢疾病The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors.

期刊：Molecules (Basel, Switzerland)发表年份：2019作者：Robert J Cassell; Krishna K Sharma; Hongyu Su; Benjamin R Cummins; Haoyue Cui; Kendall L Mores; Arryn T Blaine; Ryan A Altman; Richard M van Rijn
阅读更多 →

代谢疾病A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II-Induced Pressure Response in Mice.

期刊：Journal of cardiovascular pharmacology发表年份：2019作者：Mina Nishi; Kiyoaki Yonesu; Hideki Tagawa; Mikio Kato; Shinji Marumoto; Takahiro Nagayama
阅读更多 →